Funding for Indian startups slipped below $3 billion in the September quarter of 2025, marking a slowdown after back-to-back quarters of surpassing the threshold. The funding was driven by sizable debt rounds by PharmEasy and Eruditus, as well as pre-IPO deals involving Urban Company, IndiQube, and Smartworks. Late-stage deals for firms such as Gupshup, Truemeds, Kapiva, and The Sleep Company also contributed to the total. However, regulatory actions including the ban on real money gaming had a major impact during the quarter. This led to around…








